Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mesenchymal Stem Cells | 24 | 2022 | 182 | 6.040 |
Why?
|
Hematopoietic Stem Cells | 40 | 2020 | 100 | 5.300 |
Why?
|
Hemophilia A | 8 | 2023 | 25 | 4.560 |
Why?
|
Sheep | 58 | 2023 | 233 | 3.540 |
Why?
|
Hematopoietic Stem Cell Transplantation | 30 | 2016 | 94 | 3.230 |
Why?
|
Bone Marrow Cells | 23 | 2022 | 123 | 2.880 |
Why?
|
Fetal Blood | 13 | 2018 | 38 | 2.270 |
Why?
|
Factor VIII | 8 | 2023 | 25 | 2.020 |
Why?
|
Cell Differentiation | 32 | 2019 | 469 | 1.990 |
Why?
|
Fetus | 26 | 2023 | 86 | 1.880 |
Why?
|
Transplantation, Heterologous | 30 | 2015 | 122 | 1.860 |
Why?
|
Antigens, CD34 | 26 | 2019 | 57 | 1.800 |
Why?
|
Stem Cells | 11 | 2018 | 313 | 1.640 |
Why?
|
Genetic Vectors | 14 | 2022 | 120 | 1.580 |
Why?
|
Animals | 76 | 2023 | 7542 | 1.580 |
Why?
|
Graft Survival | 13 | 2016 | 313 | 1.560 |
Why?
|
Mesenchymal Stem Cell Transplantation | 10 | 2018 | 81 | 1.470 |
Why?
|
Stem Cell Niche | 4 | 2019 | 27 | 1.320 |
Why?
|
Endothelial Cells | 5 | 2022 | 189 | 1.320 |
Why?
|
Cytomegalovirus | 8 | 2014 | 31 | 1.310 |
Why?
|
Models, Animal | 9 | 2014 | 169 | 1.280 |
Why?
|
Pregnancy | 22 | 2023 | 997 | 1.270 |
Why?
|
Stromal Cells | 10 | 2008 | 84 | 1.260 |
Why?
|
Bone Marrow | 8 | 2022 | 70 | 1.260 |
Why?
|
Humans | 97 | 2023 | 32113 | 1.230 |
Why?
|
Hematopoiesis | 12 | 2018 | 33 | 1.170 |
Why?
|
Bone Marrow Transplantation | 8 | 2016 | 63 | 1.130 |
Why?
|
Stem Cell Transplantation | 8 | 2020 | 209 | 1.110 |
Why?
|
Regenerative Medicine | 4 | 2022 | 201 | 0.980 |
Why?
|
Dependovirus | 2 | 2022 | 18 | 0.950 |
Why?
|
Cytomegalovirus Infections | 6 | 2014 | 48 | 0.950 |
Why?
|
Cosmic Radiation | 3 | 2018 | 14 | 0.920 |
Why?
|
Cell Proliferation | 14 | 2019 | 604 | 0.870 |
Why?
|
Transplantation Chimera | 9 | 2007 | 22 | 0.870 |
Why?
|
Viral Proteins | 2 | 2013 | 35 | 0.840 |
Why?
|
Cell Communication | 3 | 2019 | 32 | 0.780 |
Why?
|
Hemophilia B | 1 | 2021 | 6 | 0.770 |
Why?
|
Cells, Cultured | 22 | 2020 | 834 | 0.760 |
Why?
|
Cell Culture Techniques | 11 | 2018 | 173 | 0.750 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2019 | 27 | 0.670 |
Why?
|
Liver | 11 | 2014 | 484 | 0.670 |
Why?
|
Fetal Therapies | 1 | 2019 | 2 | 0.660 |
Why?
|
Liver Regeneration | 2 | 2010 | 24 | 0.660 |
Why?
|
Hepatocytes | 5 | 2010 | 76 | 0.640 |
Why?
|
Cell Movement | 6 | 2012 | 169 | 0.630 |
Why?
|
Membrane Proteins | 7 | 2013 | 256 | 0.620 |
Why?
|
Female | 35 | 2023 | 20014 | 0.620 |
Why?
|
Coculture Techniques | 8 | 2019 | 81 | 0.590 |
Why?
|
Models, Biological | 6 | 2018 | 392 | 0.580 |
Why?
|
Blood Coagulation | 2 | 2023 | 15 | 0.570 |
Why?
|
Gene Transfer Techniques | 6 | 2022 | 63 | 0.570 |
Why?
|
Blood Transfusion, Intrauterine | 2 | 2016 | 4 | 0.560 |
Why?
|
Cell Division | 8 | 2005 | 99 | 0.550 |
Why?
|
Occupational Exposure | 2 | 2016 | 232 | 0.550 |
Why?
|
Killer Cells, Natural | 5 | 2012 | 25 | 0.540 |
Why?
|
RNA-Binding Proteins | 2 | 2013 | 68 | 0.530 |
Why?
|
Intestines | 2 | 2013 | 61 | 0.520 |
Why?
|
Hematologic Diseases | 1 | 2015 | 23 | 0.510 |
Why?
|
Genetic Engineering | 2 | 2012 | 18 | 0.510 |
Why?
|
DNA, Viral | 3 | 2014 | 54 | 0.510 |
Why?
|
Phenotype | 12 | 2019 | 632 | 0.490 |
Why?
|
Culture Media, Serum-Free | 4 | 2008 | 16 | 0.490 |
Why?
|
Immunomodulation | 2 | 2013 | 32 | 0.470 |
Why?
|
Placenta | 3 | 2023 | 74 | 0.470 |
Why?
|
Postural Balance | 1 | 2016 | 182 | 0.460 |
Why?
|
Hemarthrosis | 2 | 2011 | 4 | 0.450 |
Why?
|
Dendritic Cells | 2 | 2018 | 59 | 0.450 |
Why?
|
Prenatal Diagnosis | 3 | 2023 | 24 | 0.440 |
Why?
|
Viral Envelope Proteins | 1 | 2013 | 10 | 0.440 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2013 | 29 | 0.440 |
Why?
|
Immediate-Early Proteins | 1 | 2013 | 9 | 0.440 |
Why?
|
Pesticides | 1 | 2016 | 199 | 0.440 |
Why?
|
Complement System Proteins | 1 | 2013 | 9 | 0.440 |
Why?
|
Receptor, EphB2 | 1 | 2013 | 4 | 0.440 |
Why?
|
Transduction, Genetic | 5 | 2013 | 42 | 0.430 |
Why?
|
Flow Cytometry | 17 | 2011 | 185 | 0.430 |
Why?
|
Glycoproteins | 1 | 2013 | 45 | 0.430 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 244 | 0.420 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 71 | 0.420 |
Why?
|
Transients and Migrants | 1 | 2016 | 297 | 0.420 |
Why?
|
Genetic Diseases, Inborn | 3 | 2020 | 12 | 0.410 |
Why?
|
Retroviridae | 9 | 2012 | 28 | 0.400 |
Why?
|
Disease Models, Animal | 3 | 2018 | 1022 | 0.390 |
Why?
|
Prenatal Care | 3 | 2022 | 51 | 0.390 |
Why?
|
Therapeutics | 1 | 2010 | 2 | 0.370 |
Why?
|
Gestational Age | 6 | 2014 | 121 | 0.360 |
Why?
|
Cell Lineage | 8 | 2013 | 71 | 0.360 |
Why?
|
Mice | 18 | 2019 | 2484 | 0.350 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2007 | 6 | 0.350 |
Why?
|
Adult | 13 | 2023 | 9380 | 0.350 |
Why?
|
Liver Diseases | 1 | 2010 | 70 | 0.340 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 104 | 0.340 |
Why?
|
Hispanic Americans | 1 | 2016 | 940 | 0.340 |
Why?
|
Immune Tolerance | 4 | 2015 | 71 | 0.340 |
Why?
|
Docosahexaenoic Acids | 1 | 2009 | 21 | 0.330 |
Why?
|
Apoptosis | 3 | 2016 | 360 | 0.330 |
Why?
|
RNA, Messenger | 8 | 2013 | 508 | 0.330 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2008 | 8 | 0.320 |
Why?
|
Antigens, CD | 10 | 2008 | 103 | 0.310 |
Why?
|
Recombinant Proteins | 6 | 2020 | 247 | 0.310 |
Why?
|
Cell Line | 8 | 2019 | 435 | 0.300 |
Why?
|
Immunophenotyping | 11 | 2009 | 50 | 0.300 |
Why?
|
Time Factors | 10 | 2010 | 2150 | 0.290 |
Why?
|
Transplantation, Homologous | 5 | 2016 | 151 | 0.280 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2009 | 201 | 0.280 |
Why?
|
Endothelium, Vascular | 3 | 1997 | 156 | 0.270 |
Why?
|
Gene Expression | 4 | 2016 | 338 | 0.270 |
Why?
|
Pancytopenia | 2 | 1996 | 3 | 0.260 |
Why?
|
Fluorescent Dyes | 2 | 2019 | 48 | 0.250 |
Why?
|
Sheep, Domestic | 2 | 2016 | 18 | 0.240 |
Why?
|
Stem Cell Factor | 6 | 2010 | 13 | 0.240 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 726 | 0.230 |
Why?
|
Cell Separation | 4 | 2009 | 92 | 0.230 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2007 | 29 | 0.220 |
Why?
|
Male | 13 | 2022 | 19216 | 0.220 |
Why?
|
Neoplasms | 1 | 2010 | 728 | 0.220 |
Why?
|
Uterus | 2 | 2019 | 103 | 0.220 |
Why?
|
Mesoderm | 1 | 2002 | 14 | 0.220 |
Why?
|
Polymerase Chain Reaction | 7 | 2014 | 198 | 0.210 |
Why?
|
Transgenes | 5 | 2008 | 48 | 0.210 |
Why?
|
Tissue Distribution | 2 | 2013 | 61 | 0.210 |
Why?
|
Neurons | 1 | 2005 | 410 | 0.200 |
Why?
|
Organoids | 1 | 2022 | 94 | 0.190 |
Why?
|
Factor IX | 1 | 2021 | 11 | 0.190 |
Why?
|
Chimera | 4 | 1998 | 10 | 0.190 |
Why?
|
DNA Damage | 2 | 2018 | 99 | 0.190 |
Why?
|
Injections, Intraperitoneal | 3 | 2011 | 45 | 0.190 |
Why?
|
Interleukin-6 | 4 | 2012 | 247 | 0.180 |
Why?
|
Erythropoiesis | 1 | 2020 | 7 | 0.180 |
Why?
|
Multipotent Stem Cells | 1 | 2020 | 17 | 0.180 |
Why?
|
Kidney | 2 | 2010 | 518 | 0.180 |
Why?
|
Microtechnology | 1 | 2019 | 4 | 0.170 |
Why?
|
Radiation Injuries | 2 | 2019 | 76 | 0.170 |
Why?
|
Anemia | 1 | 2020 | 58 | 0.170 |
Why?
|
Kinetics | 4 | 2009 | 209 | 0.170 |
Why?
|
Islets of Langerhans | 2 | 2010 | 76 | 0.170 |
Why?
|
Antigens, CD7 | 2 | 2010 | 4 | 0.170 |
Why?
|
Consensus | 1 | 2019 | 85 | 0.160 |
Why?
|
Weightlessness | 1 | 2018 | 8 | 0.160 |
Why?
|
Solar Energy | 1 | 2018 | 4 | 0.160 |
Why?
|
Bystander Effect | 1 | 2018 | 6 | 0.160 |
Why?
|
Protons | 1 | 2018 | 23 | 0.160 |
Why?
|
Fetal Tissue Transplantation | 3 | 2005 | 5 | 0.150 |
Why?
|
Ferrets | 1 | 2018 | 20 | 0.150 |
Why?
|
Immunity, Innate | 1 | 2018 | 75 | 0.150 |
Why?
|
Interleukin-8 | 1 | 1997 | 26 | 0.150 |
Why?
|
Indocyanine Green | 1 | 2018 | 13 | 0.150 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 52 | 0.150 |
Why?
|
Biocompatible Materials | 2 | 2010 | 232 | 0.150 |
Why?
|
Membrane Glycoproteins | 3 | 2009 | 101 | 0.150 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 53 | 0.150 |
Why?
|
Iron | 1 | 2018 | 116 | 0.150 |
Why?
|
Infant, Newborn | 4 | 2011 | 672 | 0.140 |
Why?
|
Nanoparticles | 1 | 2018 | 52 | 0.140 |
Why?
|
Splenomegaly | 1 | 2016 | 7 | 0.140 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 9 | 0.140 |
Why?
|
Regeneration | 1 | 2018 | 170 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 23 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 263 | 0.140 |
Why?
|
Chemokine CXCL12 | 1 | 2016 | 25 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 291 | 0.140 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 134 | 0.140 |
Why?
|
Osteoblasts | 2 | 2014 | 45 | 0.130 |
Why?
|
Base Sequence | 3 | 2012 | 252 | 0.130 |
Why?
|
Colony-Forming Units Assay | 7 | 2010 | 19 | 0.130 |
Why?
|
Microscopy, Confocal | 2 | 2013 | 65 | 0.130 |
Why?
|
Purkinje Fibers | 2 | 2006 | 3 | 0.130 |
Why?
|
Wounds and Injuries | 1 | 2018 | 253 | 0.130 |
Why?
|
Fetal Diseases | 3 | 2004 | 19 | 0.130 |
Why?
|
Electromagnetic Fields | 1 | 2015 | 26 | 0.130 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 48 | 0.130 |
Why?
|
North Carolina | 2 | 2020 | 1538 | 0.130 |
Why?
|
Nerve Tissue Proteins | 2 | 2013 | 120 | 0.120 |
Why?
|
Muscle, Smooth | 2 | 2006 | 68 | 0.120 |
Why?
|
Antibodies, Monoclonal | 3 | 2008 | 246 | 0.120 |
Why?
|
Transplantation, Autologous | 3 | 2015 | 80 | 0.120 |
Why?
|
Opportunistic Infections | 1 | 1994 | 17 | 0.120 |
Why?
|
beta-Galactosidase | 4 | 2002 | 20 | 0.120 |
Why?
|
Amniotic Fluid | 1 | 2015 | 86 | 0.120 |
Why?
|
Fetal Development | 1 | 2014 | 26 | 0.120 |
Why?
|
Kanamycin Kinase | 2 | 2012 | 5 | 0.120 |
Why?
|
Virus Replication | 1 | 2014 | 42 | 0.120 |
Why?
|
Lung | 2 | 2014 | 249 | 0.110 |
Why?
|
Cytokines | 2 | 2018 | 256 | 0.110 |
Why?
|
Immune Evasion | 1 | 2013 | 2 | 0.110 |
Why?
|
Immunity, Humoral | 1 | 2013 | 13 | 0.110 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2003 | 10 | 0.110 |
Why?
|
Secretory Vesicles | 1 | 2013 | 4 | 0.110 |
Why?
|
Case-Control Studies | 1 | 2016 | 898 | 0.110 |
Why?
|
Antibodies, Viral | 1 | 2013 | 58 | 0.110 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2003 | 18 | 0.110 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 359 | 0.110 |
Why?
|
Virus Latency | 1 | 2012 | 7 | 0.110 |
Why?
|
Antigens, Viral | 1 | 2012 | 21 | 0.110 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 71 | 0.110 |
Why?
|
Intestine, Small | 1 | 2013 | 40 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 153 | 0.110 |
Why?
|
Growth Substances | 2 | 2006 | 8 | 0.110 |
Why?
|
Transfection | 3 | 2005 | 191 | 0.110 |
Why?
|
Embryo, Mammalian | 2 | 2004 | 31 | 0.110 |
Why?
|
Tissue Engineering | 2 | 2010 | 656 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 85 | 0.100 |
Why?
|
Gene Expression Profiling | 2 | 2005 | 322 | 0.100 |
Why?
|
Fibroblasts | 1 | 2012 | 111 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2012 | 37 | 0.100 |
Why?
|
Receptors, Virus | 1 | 2012 | 14 | 0.100 |
Why?
|
Age Factors | 3 | 2011 | 1189 | 0.100 |
Why?
|
HLA Antigens | 1 | 2012 | 40 | 0.100 |
Why?
|
Down-Regulation | 1 | 2012 | 142 | 0.100 |
Why?
|
Isoantibodies | 1 | 2011 | 12 | 0.100 |
Why?
|
Sus scrofa | 1 | 2011 | 46 | 0.100 |
Why?
|
Remission Induction | 1 | 2011 | 84 | 0.100 |
Why?
|
Signal Transduction | 2 | 2019 | 682 | 0.100 |
Why?
|
Species Specificity | 2 | 2009 | 90 | 0.100 |
Why?
|
Myoblasts, Cardiac | 1 | 2011 | 1 | 0.100 |
Why?
|
Insulin | 2 | 2010 | 367 | 0.090 |
Why?
|
Hemorrhage | 1 | 2011 | 100 | 0.090 |
Why?
|
Heart Defects, Congenital | 1 | 2011 | 31 | 0.090 |
Why?
|
Cell Survival | 2 | 2009 | 285 | 0.090 |
Why?
|
Virus Integration | 1 | 2010 | 5 | 0.090 |
Why?
|
Genes | 1 | 2010 | 15 | 0.090 |
Why?
|
Epidermal Growth Factor | 1 | 2010 | 27 | 0.090 |
Why?
|
Cell Adhesion | 4 | 2010 | 108 | 0.090 |
Why?
|
HIV-1 | 1 | 2010 | 45 | 0.090 |
Why?
|
Umbilical Veins | 3 | 2004 | 13 | 0.090 |
Why?
|
Middle Aged | 4 | 2020 | 11839 | 0.090 |
Why?
|
Coagulants | 1 | 2009 | 4 | 0.090 |
Why?
|
Partial Thromboplastin Time | 1 | 2009 | 8 | 0.090 |
Why?
|
Codon, Nonsense | 1 | 2009 | 6 | 0.090 |
Why?
|
Immunosuppression | 1 | 2010 | 121 | 0.090 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2009 | 6 | 0.090 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 28 | 0.090 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 2008 | 7 | 0.090 |
Why?
|
Receptors, Growth Factor | 1 | 1999 | 2 | 0.090 |
Why?
|
Antigens, Surface | 2 | 2001 | 24 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 72 | 0.090 |
Why?
|
Immunoassay | 1 | 2009 | 16 | 0.090 |
Why?
|
Exons | 1 | 2009 | 52 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2009 | 16 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2009 | 45 | 0.090 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1999 | 18 | 0.090 |
Why?
|
Organic Chemicals | 1 | 2009 | 7 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 4 | 2012 | 91 | 0.080 |
Why?
|
Mitosis | 1 | 2009 | 25 | 0.080 |
Why?
|
Thymus Gland | 4 | 2008 | 16 | 0.080 |
Why?
|
Organ Specificity | 3 | 2005 | 81 | 0.080 |
Why?
|
Interleukin-3 | 3 | 2003 | 11 | 0.080 |
Why?
|
Annexin A5 | 1 | 2009 | 8 | 0.080 |
Why?
|
DNA Fragmentation | 1 | 2009 | 7 | 0.080 |
Why?
|
Germ Cells | 1 | 2009 | 10 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 1 | 2009 | 15 | 0.080 |
Why?
|
Caspase 3 | 1 | 2009 | 33 | 0.080 |
Why?
|
Mice, Inbred NOD | 4 | 2015 | 25 | 0.080 |
Why?
|
Vitronectin | 1 | 2008 | 6 | 0.080 |
Why?
|
DNA | 3 | 2022 | 226 | 0.080 |
Why?
|
Cell Fusion | 1 | 2008 | 4 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 105 | 0.080 |
Why?
|
Cell-Derived Microparticles | 1 | 2008 | 6 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 3 | 2011 | 56 | 0.080 |
Why?
|
Fibronectins | 1 | 2008 | 36 | 0.080 |
Why?
|
Brain | 2 | 2014 | 951 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2008 | 9 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 190 | 0.080 |
Why?
|
Treatment Outcome | 1 | 2016 | 3306 | 0.080 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2008 | 6 | 0.080 |
Why?
|
Myocardium | 2 | 2006 | 186 | 0.080 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2008 | 17 | 0.080 |
Why?
|
Clone Cells | 1 | 2007 | 36 | 0.080 |
Why?
|
Astronauts | 2 | 2018 | 8 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2005 | 69 | 0.080 |
Why?
|
Culture Media, Conditioned | 2 | 2018 | 51 | 0.070 |
Why?
|
Injections | 1 | 2007 | 64 | 0.070 |
Why?
|
Tumor Cells, Cultured | 2 | 2018 | 171 | 0.070 |
Why?
|
Severe Combined Immunodeficiency | 2 | 1997 | 5 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 633 | 0.070 |
Why?
|
Mitochondria | 1 | 2008 | 187 | 0.070 |
Why?
|
ADP-ribosyl Cyclase | 2 | 2004 | 4 | 0.070 |
Why?
|
Aged | 2 | 2020 | 10314 | 0.070 |
Why?
|
Coiled Bodies | 1 | 2006 | 2 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 835 | 0.070 |
Why?
|
Gastroparesis | 1 | 2006 | 10 | 0.070 |
Why?
|
Interleukin-1 | 2 | 1997 | 33 | 0.070 |
Why?
|
Diabetic Neuropathies | 1 | 2006 | 24 | 0.070 |
Why?
|
Proviruses | 1 | 2005 | 3 | 0.070 |
Why?
|
Microscopy, Fluorescence | 3 | 2018 | 88 | 0.060 |
Why?
|
Surface Properties | 3 | 2010 | 32 | 0.060 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 8 | 0.060 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2005 | 24 | 0.060 |
Why?
|
Mice, SCID | 3 | 2015 | 71 | 0.060 |
Why?
|
Spermatozoa | 1 | 2005 | 28 | 0.060 |
Why?
|
Heart | 1 | 2006 | 177 | 0.060 |
Why?
|
Tissue Donors | 2 | 2004 | 198 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2004 | 38 | 0.060 |
Why?
|
Transplantation | 1 | 2004 | 13 | 0.060 |
Why?
|
Cell Count | 1 | 2004 | 47 | 0.060 |
Why?
|
Fetal Heart | 1 | 2004 | 5 | 0.060 |
Why?
|
Brain Tissue Transplantation | 1 | 2004 | 3 | 0.060 |
Why?
|
Gastrointestinal Tract | 1 | 2003 | 29 | 0.060 |
Why?
|
Fluorescence | 2 | 2018 | 20 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2010 | 538 | 0.050 |
Why?
|
Bioreactors | 1 | 2003 | 60 | 0.050 |
Why?
|
Aging | 1 | 2009 | 946 | 0.050 |
Why?
|
Sequence Deletion | 2 | 2012 | 40 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 767 | 0.050 |
Why?
|
Erythropoietin | 2 | 2020 | 30 | 0.050 |
Why?
|
Parturition | 1 | 2022 | 10 | 0.050 |
Why?
|
Bone and Bones | 2 | 2018 | 94 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 50 | 0.050 |
Why?
|
DNA Primers | 2 | 2012 | 91 | 0.050 |
Why?
|
Antibody Specificity | 3 | 2008 | 13 | 0.050 |
Why?
|
Child | 2 | 2022 | 2441 | 0.050 |
Why?
|
Protein Structure, Tertiary | 2 | 2012 | 99 | 0.050 |
Why?
|
Protein Binding | 2 | 2012 | 201 | 0.050 |
Why?
|
Photoelectron Spectroscopy | 2 | 2010 | 2 | 0.040 |
Why?
|
Brazil | 1 | 2020 | 16 | 0.040 |
Why?
|
Hematinics | 1 | 2020 | 6 | 0.040 |
Why?
|
Gold | 2 | 2010 | 18 | 0.040 |
Why?
|
Hemoglobins | 1 | 2020 | 49 | 0.040 |
Why?
|
Fetal Viability | 1 | 1999 | 2 | 0.040 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1999 | 3 | 0.040 |
Why?
|
Macrophages | 2 | 2003 | 191 | 0.040 |
Why?
|
Adsorption | 2 | 2010 | 5 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 1999 | 17 | 0.040 |
Why?
|
Integrins | 1 | 1999 | 41 | 0.040 |
Why?
|
Antibodies | 1 | 1999 | 52 | 0.040 |
Why?
|
Neutrons | 1 | 2019 | 1 | 0.040 |
Why?
|
Gamma Rays | 1 | 2019 | 25 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 70 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 1999 | 124 | 0.040 |
Why?
|
Bleomycin | 1 | 2018 | 10 | 0.040 |
Why?
|
Plasmodium falciparum | 1 | 1998 | 5 | 0.040 |
Why?
|
Endothelium | 1 | 1998 | 7 | 0.040 |
Why?
|
Databases, Factual | 1 | 2020 | 355 | 0.040 |
Why?
|
Histones | 1 | 2018 | 53 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2018 | 125 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 55 | 0.040 |
Why?
|
Erythrocytes | 1 | 1998 | 48 | 0.040 |
Why?
|
Patient Selection | 1 | 2020 | 276 | 0.040 |
Why?
|
Phagocytosis | 1 | 2018 | 14 | 0.040 |
Why?
|
DNA Repair | 1 | 2018 | 64 | 0.040 |
Why?
|
Muscles | 1 | 2018 | 62 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2018 | 74 | 0.040 |
Why?
|
Chemotaxis | 1 | 2018 | 24 | 0.040 |
Why?
|
Blotting, Western | 2 | 2012 | 289 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2011 | 24 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 19 | 0.040 |
Why?
|
Interferon-gamma | 1 | 1997 | 57 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 1997 | 51 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 91 | 0.040 |
Why?
|
Hot Temperature | 1 | 1997 | 71 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 876 | 0.040 |
Why?
|
Body Burden | 1 | 2016 | 7 | 0.040 |
Why?
|
Wound Healing | 1 | 2018 | 185 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1996 | 2 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1996 | 17 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2012 | 36 | 0.040 |
Why?
|
Thrombopoietin | 2 | 2010 | 4 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2016 | 84 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 495 | 0.030 |
Why?
|
HLA-DQ Antigens | 1 | 1996 | 8 | 0.030 |
Why?
|
DNA Probes | 1 | 1996 | 19 | 0.030 |
Why?
|
Immunomagnetic Separation | 2 | 2011 | 4 | 0.030 |
Why?
|
Genome, Human | 1 | 2016 | 132 | 0.030 |
Why?
|
Lymphocytes | 2 | 2010 | 57 | 0.030 |
Why?
|
Chondrogenesis | 1 | 2015 | 19 | 0.030 |
Why?
|
Osteogenesis | 1 | 2015 | 82 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2006 | 167 | 0.030 |
Why?
|
Ganciclovir | 1 | 1994 | 23 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1994 | 23 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2008 | 141 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 1994 | 51 | 0.030 |
Why?
|
Interleukin-4 | 1 | 1994 | 22 | 0.030 |
Why?
|
Neutralization Tests | 1 | 2013 | 12 | 0.030 |
Why?
|
Capsid | 1 | 2013 | 8 | 0.030 |
Why?
|
Myocytes, Cardiac | 2 | 2004 | 86 | 0.030 |
Why?
|
Rats | 2 | 2011 | 1596 | 0.030 |
Why?
|
Epitopes | 1 | 2013 | 24 | 0.030 |
Why?
|
Luciferases | 1 | 2013 | 32 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2013 | 90 | 0.030 |
Why?
|
United States | 1 | 2022 | 3976 | 0.030 |
Why?
|
Autocrine Communication | 1 | 2003 | 7 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2012 | 11 | 0.030 |
Why?
|
Genome, Viral | 1 | 2012 | 10 | 0.030 |
Why?
|
Mutagenesis | 1 | 2012 | 33 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 2012 | 16 | 0.030 |
Why?
|
Cricetinae | 1 | 2012 | 39 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2012 | 22 | 0.030 |
Why?
|
Thrombin | 1 | 2012 | 16 | 0.030 |
Why?
|
Polysaccharides | 1 | 2012 | 13 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 24 | 0.030 |
Why?
|
Viral Load | 1 | 2012 | 70 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 285 | 0.030 |
Why?
|
Cell Transplantation | 2 | 2004 | 64 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2020 | 3510 | 0.020 |
Why?
|
Blotting, Southern | 2 | 2004 | 24 | 0.020 |
Why?
|
Cell Cycle | 1 | 2011 | 77 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2011 | 8 | 0.020 |
Why?
|
Rats, Nude | 1 | 2011 | 43 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 30 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 51 | 0.020 |
Why?
|
Radioligand Assay | 1 | 2010 | 20 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2002 | 16 | 0.020 |
Why?
|
Interleukin-2 | 2 | 2002 | 30 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2010 | 64 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 137 | 0.020 |
Why?
|
Sulfhydryl Compounds | 1 | 2010 | 33 | 0.020 |
Why?
|
Suspensions | 1 | 2010 | 2 | 0.020 |
Why?
|
Imidazoles | 1 | 2010 | 91 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 32 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2010 | 98 | 0.020 |
Why?
|
Interleukin-7 | 2 | 2001 | 10 | 0.020 |
Why?
|
Phosphorylation | 1 | 2010 | 229 | 0.020 |
Why?
|
Receptors, Fc | 1 | 2009 | 6 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1999 | 12 | 0.020 |
Why?
|
Lymphokines | 1 | 1999 | 13 | 0.020 |
Why?
|
Endothelial Growth Factors | 1 | 1999 | 12 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 1999 | 21 | 0.020 |
Why?
|
Molecular Structure | 1 | 2009 | 59 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 181 | 0.020 |
Why?
|
Sertoli Cells | 1 | 2009 | 6 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 105 | 0.020 |
Why?
|
Granulocytes | 2 | 2000 | 12 | 0.020 |
Why?
|
Adhesiveness | 1 | 2008 | 1 | 0.020 |
Why?
|
Focal Adhesions | 1 | 2008 | 2 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2009 | 122 | 0.020 |
Why?
|
Hydroxylation | 1 | 2008 | 4 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1999 | 112 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2008 | 18 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 301 | 0.020 |
Why?
|
Biological Assay | 1 | 2008 | 19 | 0.020 |
Why?
|
Cattle | 1 | 2008 | 103 | 0.020 |
Why?
|
Autoantigens | 1 | 2008 | 16 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 35 | 0.020 |
Why?
|
Infant | 1 | 2011 | 1061 | 0.020 |
Why?
|
Blood Glucose | 1 | 2010 | 494 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 1269 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 2006 | 10 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2006 | 84 | 0.020 |
Why?
|
Testis | 1 | 2005 | 65 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 2005 | 65 | 0.020 |
Why?
|
Computer Simulation | 1 | 2006 | 220 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 2004 | 26 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2004 | 79 | 0.010 |
Why?
|
Albumins | 1 | 2004 | 45 | 0.010 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2004 | 3 | 0.010 |
Why?
|
Femur | 1 | 2004 | 74 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2004 | 57 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 2004 | 34 | 0.010 |
Why?
|
Magnetics | 1 | 2003 | 5 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2003 | 21 | 0.010 |
Why?
|
Adipocytes | 1 | 2004 | 81 | 0.010 |
Why?
|
Biomimetics | 1 | 2003 | 6 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 148 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2003 | 55 | 0.010 |
Why?
|
Hippocampus | 1 | 2004 | 171 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 3567 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 41 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2001 | 20 | 0.010 |
Why?
|
Fetal Proteins | 1 | 2001 | 7 | 0.010 |
Why?
|
Antigens | 1 | 2001 | 31 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 70 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2001 | 40 | 0.010 |
Why?
|
Immunization | 1 | 2001 | 33 | 0.010 |
Why?
|
Antibody Formation | 1 | 2001 | 46 | 0.010 |
Why?
|
Risk Factors | 1 | 2009 | 3880 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2000 | 40 | 0.010 |
Why?
|
Integrin alpha4beta1 | 1 | 1999 | 4 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2000 | 66 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1999 | 17 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2001 | 251 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 18 | 0.010 |
Why?
|
Karyotyping | 1 | 1998 | 29 | 0.010 |
Why?
|
Granzymes | 1 | 1998 | 6 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 1998 | 20 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1998 | 114 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1997 | 75 | 0.010 |
Why?
|
N-Glycosyl Hydrolases | 1 | 1996 | 5 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 1996 | 24 | 0.010 |
Why?
|
X Chromosome | 1 | 1996 | 26 | 0.010 |
Why?
|
Fathers | 1 | 1996 | 12 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1996 | 25 | 0.010 |
Why?
|